Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCroda International Regulatory News (CRDA)

Share Price Information for Croda International (CRDA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,065.00
Bid: 4,060.00
Ask: 4,061.00
Change: 38.00 (0.94%)
Spread: 1.00 (0.025%)
Open: 4,049.00
High: 4,077.00
Low: 4,022.00
Prev. Close: 4,027.00
CRDA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

11 May 2012 16:26

RNS Number : 2127D
Croda International PLC
11 May 2012
 



Croda International Plc

 

11 May 2012

 

NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY OR CONNECTED PERSONS

 

In accordance with Disclosure Rule 3.1.4R(1), I hereby inform you that Croda International Plc ("the Company") was notified on 11 May 2012, that the following transactions took place in relation to the Croda International Plc Share Incentive Plan ("SIP") on 10 May 2012. The SIP is an all-employee trust arrangement approved by HM Revenue and Customs, under which employees are able to buy ordinary shares in the Company of 10p each, using deductions from salary in each monthly pay period, and receive allocations of matching free ordinary shares ("matching shares").

 

1.

The SIP trustee (Capita IRG Trustees Limited) acquired 2,889 ordinary shares by purchase in the market on 10 May 2012 at a total cost of £61,563.95 and allocated them to employees participating in the SIP as partnership shares.

 

2.

The SIP trustee (Capita IRG Trustees Limited) also acquired 2,889 ordinary shares by purchase in the market on 10 May 2012 at a total cost of £61,563.95 and allocated them to employees participating in the SIP as matching shares.

 

3.

The following directors and persons discharging managerial responsibilities purchased the number of ordinary shares of 10p set out against their names below, at a price of 2113p per ordinary share, and were allocated for no consideration the number of matching shares set out against their names below:

 

Name

Role

 

 

Number of ordinary

shares purchased

Number of matching

shares allocated

S E Foots

Executive Director

6

6

M S Christie

Executive Director

5

5

K Layden

Executive Director

6

6

D E Barraclough

PDMR

6

6

S E Breene

PDMR

6

6

M W Heijbroek

PDMR

6

6

G L Myers

PDMR

6

6

K M Nutbrown

PDMR

6

6

A L Scott

PDMR

6

6

 

This notification is made in order to satisfy both section 793 of the Companies Act 2006 and Disclosure and Transparency Rule 3.1.2.

 

 

 

 

Louise Scott

Company Secretary and Legal Counsel

Croda International Plc

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSEFLFFLEFLBBZ
Date   Source Headline
12th Sep 20238:56 amRNSDirector/PDMR Shareholding
11th Aug 20232:26 pmRNSDirector/PDMR Shareholding
1st Aug 20237:13 amRNSDirector Declaration
25th Jul 20237:00 amRNSResults for the six months ended 30 June 2023
11th Jul 20232:57 pmRNSDirector/PDMR Shareholding
4th Jul 20238:02 amRNSCroda completes acquisition of Solus Biotech
26th Jun 202310:46 amRNSHolding(s) in Company
13th Jun 20233:55 pmRNSDirector/PDMR Shareholding
12th Jun 20232:06 pmRNSDirector/PDMR Shareholding
9th Jun 20237:00 amRNSTrading update
31st May 20232:47 pmRNSDirector/PDMR Shareholding
26th May 20233:51 pmRNSDirector/PDMR Shareholding
11th May 20234:05 pmRNSDirector/PDMR Shareholding
3rd May 20233:08 pmRNSDirector/PDMR Shareholding
3rd May 20233:00 pmRNSDirector/PDMR Shareholding
2nd May 20232:30 pmRNSDirector/PDMR Shareholding
27th Apr 20239:18 amRNSResult of AGM
24th Apr 20234:49 pmRNSDirector/PDMR Shareholding
12th Apr 20232:00 pmRNSDirector/PDMR Shareholding
28th Mar 20233:51 pmRNSDirector/PDMR Shareholding
28th Mar 20233:50 pmRNSDirector/PDMR Shareholding
28th Mar 20233:47 pmRNSDirector/PDMR Shareholding
28th Mar 20233:46 pmRNSDirector/PDMR Shareholding
28th Mar 20233:44 pmRNSDirector/PDMR Shareholding
28th Mar 20233:42 pmRNSDirector/PDMR Shareholding
28th Mar 20233:41 pmRNSDirector/PDMR Shareholding
28th Mar 20233:41 pmRNSDirector/PDMR Shareholding
27th Mar 20233:52 pmRNSDirector/PDMR Shareholding
27th Mar 20233:48 pmRNSDirector/PDMR Shareholding
24th Mar 202310:57 amRNSDirector/PDMR Shareholding
24th Mar 202310:31 amRNSDirectorate Change
17th Mar 20235:12 pmRNSAnnual Financial Report
17th Mar 20232:30 pmRNSDirector/PDMR Shareholding
17th Mar 202310:53 amRNSDirector/PDMR Shareholding
13th Mar 20232:02 pmRNSDirector/PDMR Shareholding
3rd Mar 202311:57 amRNSDirector/PDMR Shareholding
28th Feb 20239:21 amRNSDirectorate Change
28th Feb 20237:00 amRNSResults for the year ended 31 December 2022
13th Feb 20232:14 pmRNSDirector/PDMR Shareholding
6th Feb 20237:00 amRNSAcquisition of Solus Biotech
11th Jan 20233:45 pmRNSDirector/PDMR Shareholding
13th Dec 20223:04 pmRNSDirector/PDMR Shareholding
6th Dec 202212:36 pmRNSDirector/PDMR Shareholding
14th Nov 20223:33 pmRNSHolding(s) in Company
11th Nov 20222:04 pmRNSDirector/PDMR Shareholding
11th Nov 202210:37 amRNSDirector/PDMR Shareholding
11th Nov 202210:33 amRNSDirector/PDMR Shareholding
8th Nov 202211:23 amRNSDirector/PDMR Shareholding
7th Nov 20226:11 pmRNSDirector/PDMR Shareholding
7th Nov 20227:00 amRNSJez Maiden to retire as Group Finance Director

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.